You are here

Bolt Biotherapeutics

Bolt Biotherapeutics to lay off staff, abandon lead ADC candidate

BioPharma Dive

Wed, 05/15/24 - 10:53 pm

Bolt Biotherapeutics

trastuzumab imbotolimod

clinical trials

Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours

Clinical Trials Arena

Fri, 03/31/23 - 10:22 am

Bolt Biotherapeutics

Bristol Myers Squibb

IPO tracker: 2021 gets started with a flurry of new offerings

Endpoints

Mon, 01/25/21 - 10:43 am

Sana Biotechnology

Sensei Biotherapeutics

Bolt Biotherapeutics

Terns Pharmaceuticals

Gracell Biotechnologies

Cullinan Oncology

Bolt Biotherapeutics nabs $93.5M to push Provenge inventor's new idea deeper in the clinic

Endpoints

Wed, 07/1/20 - 11:19 am

Bolt Biotherapeutics

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

Fierce Biotech

Mon, 11/11/19 - 10:44 am

Bolt Biotherapeutics

immuno-oncology

clinical trials